Replies to post #2181 on RedHill Biopharma Ltd (RDHL)

[XWAVXALMIMAN]

I hope all 3 do well. I like the Israeli companies but Capricor is also worth checking out. It went down yesterday after an earnings report but they are using Cedars Sinai for stem cell treatment for COVID. That also have phase 3 study for muscular dystrophy and some vaccine candidates. Pluristem has other indications for their stem cells. I’m betting plenty on these stocks. No need for side bets.

[Amatuer17]

Hi Midas - check RYTM- need your help to start message board

I played on TRVN based on PDUFA date - yesterday FDA approved it and SP went $3.50 after market. I made 5 bagger in 4-5 months

Here are more details

—————
Another PDUFA play is RYTM
There is no message board so someone should start it so we can post

PDUFA date - 27th Nov
Disease - rare disease - obesity based on genetics
MOA - impacts the MC4PA gene that controls obesity and hunger.

They have 4 more trials for other sub areas also in advance stage.

As per conf call - they are looking at pricing from $200k to $400k per year
Patient population for this approval - around 1000


https://ir.rhythmtx.com/static-files/fd4e0919-4d82-47e0-afe3-8cd9b5151490